CID 3012398

Schembl4702991

Structural Information

Molecular Formula
C26H26N6O2
SMILES
CCN1C2=C(C=CC=N2)N(C(=O)C3=C1N=CC(=C3)CCOC4=C(C=C(C=C4)N5C=CN=C5)C)C
InChI
InChI=1S/C26H26N6O2/c1-4-32-24-21(26(33)30(3)22-6-5-10-28-25(22)32)15-19(16-29-24)9-13-34-23-8-7-20(14-18(23)2)31-12-11-27-17-31/h5-8,10-12,14-17H,4,9,13H2,1-3H3
InChIKey
OYZJKNRSDBZTFV-UHFFFAOYSA-N
Compound name
2-ethyl-13-[2-(4-imidazol-1-yl-2-methylphenoxy)ethyl]-9-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-10-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

7
Patents

454.21173 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 455.21901 219.7
[M+Na]+ 477.20095 229.8
[M-H]- 453.20445 225.5
[M+NH4]+ 472.24555 224.0
[M+K]+ 493.17489 224.8
[M+H-H2O]+ 437.20899 204.8
[M+HCOO]- 499.20993 231.7
[M+CH3COO]- 513.22558 226.3
[M+Na-2H]- 475.18640 219.1
[M]+ 454.21118 221.1
[M]- 454.21228 221.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe